These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 2835707)

  • 21. Treatment of immune-mediated, dysimmune neuropathies.
    Finsterer J
    Acta Neurol Scand; 2005 Aug; 112(2):115-25. PubMed ID: 16008538
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Class II antigen expression on human cultured Schwann cells from patients with Charcot-Marie-Tooth disease.
    De Martini I; Bianchini D; Schenone A; Cadoni A; Zicca A; Zaccheo D; Mancardi GL
    Neurosci Lett; 1989 May; 100(1-3):331-4. PubMed ID: 2761783
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Possible T4-HLA class II interaction as an essential event in antigen-specific helper T lymphocyte-dependent B cell activation.
    Fischer A; Sterkers G; Charron D; Durandy A
    Eur J Immunol; 1986 Sep; 16(9):1111-6. PubMed ID: 2944748
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cyclosporine does not abrogate donor-specific class II expression in allografted human heart.
    Rose M; Navarette C; Yacoub M; Festenstein H
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):333-40. PubMed ID: 3291265
    [No Abstract]   [Full Text] [Related]  

  • 25. Differential MHC class II expression on human peripheral blood monocytes and dendritic cells.
    Brooks CF; Moore M
    Immunology; 1988 Feb; 63(2):303-11. PubMed ID: 3350576
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association of HLA-DR/DQ polymorphism with chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) in Tunisian patients.
    Mrad M; Fekih-Mrissa N; Mansour M; Seyah A; Riahi A; Gritli N; Mrissa R
    Transfus Apher Sci; 2013 Dec; 49(3):623-6. PubMed ID: 23968987
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunochemical and functional analysis of HLA class II antigens induced by recombinant immune interferon on normal epidermal melanocytes.
    Tsujisaki M; Igarashi M; Sakaguchi K; Eisinger M; Herlyn M; Ferrone S
    J Immunol; 1987 Feb; 138(4):1310-6. PubMed ID: 3100635
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Application of the avidin-biotin-peroxidase complex (ABC) method with a monoclonal antibody to the HLA-DR antigen in immunoelectron microscopy].
    Chen BF; Lian P
    Zhonghua Bing Li Xue Za Zhi; 1986 Jun; 15(2):87-9. PubMed ID: 2946451
    [No Abstract]   [Full Text] [Related]  

  • 29. The conceptual introduction of the "demyelinating Schwann cell" in peripheral demyelinating neuropathies.
    Park HT; Kim JK; Tricaud N
    Glia; 2019 Apr; 67(4):571-581. PubMed ID: 30378179
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Schwann cell-derived periostin promotes autoimmune peripheral polyneuropathy via macrophage recruitment.
    Allard DE; Wang Y; Li JJ; Conley B; Xu EW; Sailer D; Kimpston C; Notini R; Smith CJ; Koseoglu E; Starmer J; Zeng XL; Howard JF; Hoke A; Scherer SS; Su MA
    J Clin Invest; 2018 Oct; 128(10):4727-4741. PubMed ID: 30222134
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Examination of two anti-HLA-DR-like monoclonal antibodies.
    Nikolova EB
    Haematologia (Budap); 1986; 19(2):133-40. PubMed ID: 2428703
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phenotypic and proliferative properties of Schwann cells from nerves of diabetic patients.
    Scarpini E; Doronzo R; Baron P; Moggio M; Basellini A; Scarlato G
    Int J Clin Pharmacol Res; 1992; 12(5-6):211-5. PubMed ID: 1301402
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interferon-gamma regulates the T cell response to precursor nevi and biologically early melanoma.
    Guerry D; Alexander MA; Elder DE; Herlyn MF
    J Immunol; 1987 Jul; 139(1):305-12. PubMed ID: 3108402
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Xenogeneic recognition of soluble and cell surface HLA class II antigens by proliferative murine T cells.
    Viguier M; Lotteau V; Charron D; Debré P
    Eur J Immunol; 1987 Nov; 17(11):1540-6. PubMed ID: 2960540
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Axonal neuropathy associated with interferon-alpha treatment for hepatitis C: HLA-DR immunoreactivity in Schwann cells.
    Quattrini A; Comi G; Nemni R; Martinelli V; Villa A; Caimi M; Wrabetz L; Canal N
    Acta Neuropathol; 1997 Nov; 94(5):504-8. PubMed ID: 9386785
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HLA-D/DR identity results in a positive CML reaction.
    Buc M; Porubská S; Bencová M; Nyulassy S; Stefanovic J
    Folia Biol (Praha); 1989; 35(2):78-89. PubMed ID: 2659391
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Induction of HLA-DR antigen expression in human endometrial epithelial cells in vitro by recombinant gamma-interferon.
    Tabibzadeh SS; Gerber MA; Satyaswaroop PG
    Am J Pathol; 1986 Oct; 125(1):90-6. PubMed ID: 2430458
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Analysis of the molecular specificities of anti-class II monoclonal antibodies by using L cell transfectants expressing HLA class II molecules.
    Klohe EP; Watts R; Bahl M; Alber C; Yu WY; Anderson R; Silver J; Gregersen PK; Karr RW
    J Immunol; 1988 Sep; 141(6):2158-64. PubMed ID: 2459201
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The density of HLA-DR antigen expression on alveolar macrophages is increased in pulmonary sarcoidosis.
    Campbell DA; du Bois RM; Butcher RG; Poulter LW
    Clin Exp Immunol; 1986 Jul; 65(1):165-71. PubMed ID: 3791697
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epithelial HLA-DR expression and lymphocyte subsets in gastric mucosa in type B chronic gastritis.
    Papadimitriou CS; Ioachim-Velogianni EE; Tsianos EB; Moutsopoulos HM
    Virchows Arch A Pathol Anat Histopathol; 1988; 413(3):197-204. PubMed ID: 3135657
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.